AI study to sort lung nodules after past cancer treatment
Part of Cancer, Lungs & breathing clinical trials.
This study uses computer tools (AI) and detailed scan patterns to better classify new lung nodules in people who previously had curative-intent cancer treatment. It may help doctors decide whether a nodule is likely benign or cancer, using your CT scan and related medical history.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’ve had a solid-organ cancer treated with the goal of cure within the last 10 years
- You now have a new lung nodule seen on a recent chest CT scan
- Your past cancer was treated with major/curative-type therapy like surgery, strong radiation, chemotherapy, or a mix
- You have the “ground truth” for what the nodule means—such as biopsy results, or clear follow-up scan changes showing it improved or worsened
- Your CT scan is detailed enough: slices are 2.5 mm or thinner, and the nodule is at least 5 mm
- Your situation is not a case of certain early “spot-only” metastases treated radically, and your previous cancer was not a blood cancer like leukemia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a new test can better identify early lung cancer in people who are being watched for an incidental lung nodule. It may help doctors decide which nodules need closer follow-up or treatment.
This study tests whether Optellum’s AI prediction tool can better identify which lung nodules found on CT scans are more likely to be cancer. You may be asked to provide specific types of CT images so the tool can be evaluated.
This study looks at lung nodules found on CT scans. Researchers will collect data from your breathing tests and CT scans to better understand how these nodules relate to lung cancer.
This trial uses a new, non-invasive way to screen for lung cancer by combining your breath, blood, and CT scan images. The goal is to figure out whether a nodule found on a CT scan is cancerous or not, which could help patients avoid unnecessary procedures.
This study uses an AI system that looks at your PET/CT scan images to figure out the exact type and genetic makeup of your non-small cell lung cancer. The goal is to improve how doctors classify and treat your cancer without needing extra invasive tests.
This trial uses artificial intelligence to improve low-dose CT scans for early lung cancer detection. If you are at higher risk due to smoking or family history, or just want a routine check, you may be able to join.
Hear when a new Lung Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.